Iridex Corp (IRIX)

$1.49 0.00 (N/A)
Market Cap 25.61M
Revenue (ttm) 48.67M
Net Income (ttm) -8.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.31%
Debt to Equity Ratio 0.79
Volume 94,100
Avg Vol 99,194
Day's Range N/A - N/A
Shares Out 17.19M
Stochastic %K 34%
Beta 0.53
Analysts Strong Buy
Price Target $2.00

Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems th...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 940 4700
Fax: 650 940 4710
Address:
1212 Terra Bella Avenue, Mountain View, United States
StudBull
StudBull Jan. 27 at 4:09 PM
$IRIX CFO keeps buying post pre-announcement. Another form 4 filed yesterday. I cannot imagine what that might imply for the upcoming Q4 ER/Call and the outlook for 2026
0 · Reply
10baggerPete
10baggerPete Jan. 26 at 10:49 PM
$IRIX nice setup , a swift burst to $2.X is on deck as a likely scenario.
0 · Reply
StudBull
StudBull Jan. 26 at 6:19 PM
$IRIX My imaginary A.I. friend said the following-- "Core view: treat IRIX as an emerging trend/turnaround long driven by improving fundamentals (revenue growth, positive Q4 cash flow, path to positive adjusted EBITDA) and aligned insider behavior (CFO buys)"
0 · Reply
Milos89
Milos89 Jan. 25 at 2:14 AM
$IRIX
0 · Reply
peepthestamp
peepthestamp Jan. 24 at 1:20 AM
$IRIX
0 · Reply
SMARTR8
SMARTR8 Jan. 22 at 12:23 AM
$IRIX still going 🔥🔥
1 · Reply
StudBull
StudBull Jan. 21 at 8:05 PM
$IRIX CFO back again buying more stock between $1.49 and $1.53. I think that's a positive
0 · Reply
StudBull
StudBull Jan. 17 at 4:33 PM
$IRIX new Form 4 filing shows CFO Dizon buying more stock yesterday (Friday 1/16) in the open market. Perhaps the strong preannounced results from earlier in the week should be viewed as a sustainable inflection versus a one time event
0 · Reply
SMARTR8
SMARTR8 Jan. 14 at 2:54 AM
Early or not interested at all 💎 $IRIX from 0.94 👉 now 1.49 (58%+ now) $DVLT from 0.489 👉 1.50 (205%+) $BKKT from 10.55 avg 👉 20 (90%+) $LEXX from 0.506 👉 0.76 (50%+) $OSRH patience will be rewarded. All just recent trades ✅️💎🎯 I have order proof for EVERY trade I ever said I took 🤝
1 · Reply
SMARTR8
SMARTR8 Jan. 13 at 1:34 PM
Every alert comes with proper risk-management 💎💎💎 $IRIX from 0.94 👉 now 1.49 (58%+ now) $DVLT from 0.489 👉 1.50 (205%+) $BKKT from 10.55 avg 👉 20 (90%+) $LEXX from 0.506 👉 0.76 (50%+) All just recent trades ✅️💎🎯
0 · Reply
Latest News on IRIX
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

Jan 12, 2026, 7:00 AM EST - 20 days ago

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025

Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management

Dec 11, 2025, 7:00 AM EST - 7 weeks ago

Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment

Dec 8, 2025, 7:00 AM EST - 7 weeks ago

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment

Iridex to Present at the Sidoti Year-End Virtual Investor Conference

Dec 5, 2025, 7:00 AM EST - 2 months ago

Iridex to Present at the Sidoti Year-End Virtual Investor Conference

IRIDEX Corporation (IRIX) Q3 2025 Earnings Call Prepared Remarks Transcript

Nov 11, 2025, 6:51 PM EST - 2 months ago

IRIDEX Corporation (IRIX) Q3 2025 Earnings Call Prepared Remarks Transcript

Iridex Reports Third Quarter 2025 Financial Results

Nov 11, 2025, 4:05 PM EST - 2 months ago

Iridex Reports Third Quarter 2025 Financial Results

Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 28, 2025, 4:05 PM EDT - 3 months ago

Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance

Sep 9, 2025, 4:05 PM EDT - 5 months ago

Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance

IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 9:09 PM EDT - 6 months ago

IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript

Iridex Reports Second Quarter 2025 Financial Results

Aug 12, 2025, 4:05 PM EDT - 6 months ago

Iridex Reports Second Quarter 2025 Financial Results

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

Jun 24, 2025, 7:00 AM EDT - 7 months ago

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Call Transcript

May 13, 2025, 9:05 PM EDT - 9 months ago

IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Call Transcript

Iridex Reports First Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 9 months ago

Iridex Reports First Quarter 2025 Financial Results

IRIDEX Changes Course

May 1, 2025, 6:00 PM EDT - 9 months ago

IRIDEX Changes Course

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 30, 2025, 4:05 PM EDT - 9 months ago

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025

IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript)

Apr 16, 2025, 7:11 PM EDT - 10 months ago

IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript)

Iridex to Host Strategic Vision Call on April 16, 2025

Apr 9, 2025, 4:05 PM EDT - 10 months ago

Iridex to Host Strategic Vision Call on April 16, 2025

IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 6:03 PM EDT - 11 months ago

IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 27, 2025, 4:05 PM EDT - 11 months ago

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

Iridex Announces Strategic Investment in the Company

Mar 19, 2025, 9:15 AM EDT - 11 months ago

Iridex Announces Strategic Investment in the Company

Iridex Comments on Recent Stock Price Volatility

Mar 14, 2025, 7:00 AM EDT - 11 months ago

Iridex Comments on Recent Stock Price Volatility

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Mar 13, 2025, 5:00 PM EDT - 11 months ago

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

Dec 18, 2024, 4:05 PM EST - 1 year ago

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

Iridex Comments on Changing Glaucoma Reimbursement Landscape

Nov 19, 2024, 8:14 AM EST - 1 year ago

Iridex Comments on Changing Glaucoma Reimbursement Landscape

IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript

Nov 16, 2024, 3:53 PM EST - 1 year ago

IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript

Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

Nov 4, 2024, 4:05 PM EST - 1 year ago

Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

Iridex Appoints Patrick Mercer as Chief Executive Officer

Oct 3, 2024, 4:05 PM EDT - 1 year ago

Iridex Appoints Patrick Mercer as Chief Executive Officer

Iridex Frustrates, But Expect A Transaction By Year-End

Aug 26, 2024, 11:16 AM EDT - 1 year ago

Iridex Frustrates, But Expect A Transaction By Year-End

IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 4:23 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript

IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript

May 17, 2024, 3:27 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript

Iridex Reports First Quarter 2024 Financial Results

May 14, 2024, 4:05 PM EDT - 1 year ago

Iridex Reports First Quarter 2024 Financial Results

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Mar 28, 2024, 7:12 PM EDT - 2 years ago

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 7:30 PM EDT - 2 years ago

IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript

Iridex Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 26, 2024, 4:05 PM EDT - 2 years ago

Iridex Reports Fourth Quarter and Full Year 2023 Financial Results

Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024

Mar 20, 2024, 4:05 PM EDT - 2 years ago

Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024

Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

Jan 24, 2024, 8:00 AM EST - 2 years ago

Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

Jan 11, 2024, 6:45 PM EST - 2 years ago

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

Dec 28, 2023, 6:00 PM EST - 2 years ago

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

Nov 27, 2023, 9:00 AM EST - 2 years ago

Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

Iridex Reports Third Quarter 2023 Financial Results and Business Update

Nov 14, 2023, 4:21 PM EST - 2 years ago

Iridex Reports Third Quarter 2023 Financial Results and Business Update

Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023

Nov 13, 2023, 9:00 AM EST - 2 years ago

Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023

Iridex Reimbursement Chaos Presents Buying Opportunity

Nov 2, 2023, 6:11 AM EDT - 2 years ago

Iridex Reimbursement Chaos Presents Buying Opportunity

Iridex to Report Third Quarter Financial Results on November 14, 2023

Oct 26, 2023, 4:22 PM EDT - 2 years ago

Iridex to Report Third Quarter Financial Results on November 14, 2023

Iridex: The Whole Is Less Than The Sum Of The Parts

Oct 4, 2023, 5:04 AM EDT - 2 years ago

Iridex: The Whole Is Less Than The Sum Of The Parts

Iridex Announces Strategic Review to Unlock Shareholder Value

Aug 29, 2023, 4:05 PM EDT - 2 years ago

Iridex Announces Strategic Review to Unlock Shareholder Value

IRIDEX Corporation (IRIX) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 8:33 PM EDT - 2 years ago

IRIDEX Corporation (IRIX) Q2 2023 Earnings Call Transcript

Iridex to Report First Quarter Financial Results on May 11, 2023

Apr 27, 2023, 4:05 PM EDT - 3 years ago

Iridex to Report First Quarter Financial Results on May 11, 2023

IRIDEX Corporation (IRIX) Q4 2022 Earnings Call Transcript

Mar 9, 2023, 10:12 PM EST - 3 years ago

IRIDEX Corporation (IRIX) Q4 2022 Earnings Call Transcript

Iridex Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 9, 2023, 4:05 PM EST - 3 years ago

Iridex Reports Fourth Quarter and Full Year 2022 Financial Results

Iridex to Present at the 35th Annual Roth Conference

Mar 7, 2023, 4:05 PM EST - 3 years ago

Iridex to Present at the 35th Annual Roth Conference

StudBull
StudBull Jan. 27 at 4:09 PM
$IRIX CFO keeps buying post pre-announcement. Another form 4 filed yesterday. I cannot imagine what that might imply for the upcoming Q4 ER/Call and the outlook for 2026
0 · Reply
10baggerPete
10baggerPete Jan. 26 at 10:49 PM
$IRIX nice setup , a swift burst to $2.X is on deck as a likely scenario.
0 · Reply
StudBull
StudBull Jan. 26 at 6:19 PM
$IRIX My imaginary A.I. friend said the following-- "Core view: treat IRIX as an emerging trend/turnaround long driven by improving fundamentals (revenue growth, positive Q4 cash flow, path to positive adjusted EBITDA) and aligned insider behavior (CFO buys)"
0 · Reply
Milos89
Milos89 Jan. 25 at 2:14 AM
$IRIX
0 · Reply
peepthestamp
peepthestamp Jan. 24 at 1:20 AM
$IRIX
0 · Reply
SMARTR8
SMARTR8 Jan. 22 at 12:23 AM
$IRIX still going 🔥🔥
1 · Reply
StudBull
StudBull Jan. 21 at 8:05 PM
$IRIX CFO back again buying more stock between $1.49 and $1.53. I think that's a positive
0 · Reply
StudBull
StudBull Jan. 17 at 4:33 PM
$IRIX new Form 4 filing shows CFO Dizon buying more stock yesterday (Friday 1/16) in the open market. Perhaps the strong preannounced results from earlier in the week should be viewed as a sustainable inflection versus a one time event
0 · Reply
SMARTR8
SMARTR8 Jan. 14 at 2:54 AM
Early or not interested at all 💎 $IRIX from 0.94 👉 now 1.49 (58%+ now) $DVLT from 0.489 👉 1.50 (205%+) $BKKT from 10.55 avg 👉 20 (90%+) $LEXX from 0.506 👉 0.76 (50%+) $OSRH patience will be rewarded. All just recent trades ✅️💎🎯 I have order proof for EVERY trade I ever said I took 🤝
1 · Reply
SMARTR8
SMARTR8 Jan. 13 at 1:34 PM
Every alert comes with proper risk-management 💎💎💎 $IRIX from 0.94 👉 now 1.49 (58%+ now) $DVLT from 0.489 👉 1.50 (205%+) $BKKT from 10.55 avg 👉 20 (90%+) $LEXX from 0.506 👉 0.76 (50%+) All just recent trades ✅️💎🎯
0 · Reply
StockScanners
StockScanners Jan. 13 at 5:04 AM
$IRIX keep watch if this holds above 1.40
0 · Reply
1inTheStink
1inTheStink Jan. 13 at 1:09 AM
$IRIX nice one today. Yeeeahhhhhhhhhhhh boyyyyyyyyyyy
0 · Reply
topstockalerts
topstockalerts Jan. 12 at 8:58 PM
Top Gainers PT2 $PASW $CIGL $OSS $OMH $IRIX
0 · Reply
topstockalerts
topstockalerts Jan. 12 at 8:21 PM
$IRIX Setting up nicely for continuation. Price is consolidating near highs. That often leads to another push 🚀.
0 · Reply
topstockalerts
topstockalerts Jan. 12 at 8:03 PM
Top Gainers PT2 $IRIX $OSS $PASW $CLRB $OMH
0 · Reply
topstockalerts
topstockalerts Jan. 12 at 6:27 PM
Top Gainers PT2 $SDOT $PASW $SOGP $IRIX $CLRB
0 · Reply
bigtuna7
bigtuna7 Jan. 12 at 5:41 PM
$IRIX Going without me :/
0 · Reply
Suki444
Suki444 Jan. 12 at 1:28 PM
$IRIX boom!!! LFG!!!🔥
0 · Reply
topstockalerts
topstockalerts Jan. 12 at 1:01 PM
Pre Market Top Gainers PT2 $ABVX $DAWN $HYFT $IRIX $JAGX
0 · Reply
StudBull
StudBull Jan. 12 at 12:42 PM
$IRIX https://iridex.gcs-web.com/news-releases/news-release-details/iridex-announces-preliminary-operational-and-financial-results-8
1 · Reply
DARKP00L
DARKP00L Jan. 12 at 12:42 PM
$IRIX 07:39 on Jan. 12 2026 Iridex Reports Preliminary Q4 2025 Revenue Of $14.6M–$14.8M, Up 15%–17% YoY, And Full-Year Revenue Of $52.5M–$52.7M, Up 8% YoY, While Achieving Positive Cash Flow And Adjusted EBITDA #tradeideas
0 · Reply
1inTheStink
1inTheStink Jan. 5 at 8:17 PM
$IRIX
0 · Reply